Boulder Diagnostics
The deal expands Oxford Immunotec’s offerings with Boulder’s marketed diagnostics—including SpiroFind® for Lyme Borreliosis, designed to detect early and long-term Borrelia infections that cause Lyme disease; GoutiFind™ for non-invasive diagnosis of Gout, obviating diagnosis by joint puncture; and Stratokine™, an assay designed to help select biologics for autoimmune disease based on monitoring and prognosis of drug response.